| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.25▲ | 3.25▲ | 3.24▲ | 3.35▼ | 3.44▼ |
| MA10 | 3.24▲ | 3.24▲ | 3.26▲ | 3.40▼ | 3.87▼ |
| MA20 | 3.25▲ | 3.26▲ | 3.29▼ | 3.53▼ | 3.92▼ |
| MA50 | 3.24▲ | 3.32▼ | 3.37▼ | 4.07▼ | 3.11▲ |
| MA100 | 3.26▲ | 3.37▼ | 3.48▼ | 4.09▼ | 2.16▲ |
| MA200 | 3.28▼ | 3.49▼ | 3.64▼ | 3.51▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.005▲ | 0.002▲ | -0.005▼ | -0.193▼ |
| RSI | 62.491▲ | 50.795▲ | 46.686▼ | 37.904▼ | 45.277▼ |
| STOCH | 56.614 | 41.314 | 21.392 | 37.519 | 14.045▼ |
| WILL %R | 0.000▲ | -51.515 | -63.636 | -84.370▼ | -94.962▼ |
| CCI | 177.193▲ | 23.038 | -9.782 | -101.872▼ | -112.859▼ |
| CDL | $ABAT Doji Candlestick Pattern Detected | Set Alert |
|
Monday, March 16, 2026 08:37 PM
Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system for people with Type 2 diabetes using basal insulin. The company also ...
|
|
Sunday, March 15, 2026 02:55 PM
Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) confirmed the launch of its most advanced generation stent, XIENCE Skypoint, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/03/26 | 3.25 | 3.365 | 3.19 | 3.27 | 3,571,910 |
| 16/03/26 | 3.36 | 3.43 | 3.21 | 3.26 | 3,295,972 |
| 13/03/26 | 3.46 | 3.54 | 3.2801 | 3.32 | 4,886,527 |
| 12/03/26 | 3.412 | 3.445 | 3.285 | 3.42 | 4,240,081 |
| 11/03/26 | 3.51 | 3.655 | 3.45 | 3.50 | 4,758,917 |
| 10/03/26 | 3.35 | 3.665 | 3.35 | 3.57 | 3,668,460 |
| 09/03/26 | 3.25 | 3.40 | 3.1607 | 3.34 | 3,255,757 |
| 06/03/26 | 3.28 | 3.50 | 3.2707 | 3.37 | 2,790,627 |
| 05/03/26 | 3.50 | 3.50 | 3.28 | 3.40 | 3,838,577 |
| 04/03/26 | 3.52 | 3.605 | 3.475 | 3.51 | 2,155,216 |
|
|
||||
|
|
||||
|
|